摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(3-fluorophenyl)isoxazol-5(4H)-one

中文名称
——
中文别名
——
英文名称
3-(3-fluorophenyl)isoxazol-5(4H)-one
英文别名
3-(3-fluorophenyl)-4H-1,2-oxazol-5-one
3-(3-fluorophenyl)isoxazol-5(4H)-one化学式
CAS
——
化学式
C9H6FNO2
mdl
——
分子量
179.151
InChiKey
OKTVTYYDZVERJK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    38.7
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    3-(3-fluorophenyl)isoxazol-5(4H)-one三氯氧磷 作用下, 生成 5-Chloro-3-(3-fluoro-phenyl)-isoxazole
    参考文献:
    名称:
    Discovery of a nonpeptidic small molecule antagonist of the human platelet thrombin receptor (PAR-1)
    摘要:
    The synthesis and biological evaluation of a series of nonpeptidic small molecule antagonists of the human platelet thrombin receptor (PAR-1) are described. Optimization of the 5-amino-3-arylisoxazole lead resulted in an approximate 100-fold increase in potency. The most potent of these compounds (54) inhibits platelet activation with IC50S of 90 nM against the thrombin receptor agonist peptide (TRAP) and 510 nM against thrombin as the agonist. Further, antagonist 54 fully blocks platelet aggregation stimulated by 1 nM thrombin for 10 min. (C) 2002 Published by Elsevier Science Ltd.
    DOI:
    10.1016/s0960-894x(01)00745-4
  • 作为产物:
    描述:
    参考文献:
    名称:
    Discovery of a nonpeptidic small molecule antagonist of the human platelet thrombin receptor (PAR-1)
    摘要:
    The synthesis and biological evaluation of a series of nonpeptidic small molecule antagonists of the human platelet thrombin receptor (PAR-1) are described. Optimization of the 5-amino-3-arylisoxazole lead resulted in an approximate 100-fold increase in potency. The most potent of these compounds (54) inhibits platelet activation with IC50S of 90 nM against the thrombin receptor agonist peptide (TRAP) and 510 nM against thrombin as the agonist. Further, antagonist 54 fully blocks platelet aggregation stimulated by 1 nM thrombin for 10 min. (C) 2002 Published by Elsevier Science Ltd.
    DOI:
    10.1016/s0960-894x(01)00745-4
点击查看最新优质反应信息

文献信息

  • Rh(III)-Catalyzed [4 + 2] Annulation of 3-Aryl-5-isoxazolone with Maleimides or Maleic Ester
    作者:Ting Wan、Chao Pi、Yangjie Wu、Xiuling Cui
    DOI:10.1021/acs.orglett.0c02283
    日期:2020.8.21
    The Rh(III)-catalyzed [4 + 2] annulation of 3-aryl-5-isoxazolones with maleimides or maleic ester has been developed, which gives synthetically important 3,4-dihydroisoquinoline derivatives in good to excellent yields. This facile protocol can tolerate a variety of functional groups, and CO2 was produced as the predominant byproduct. Notably, a C–C bond and a C–N bond were formed simultaneously. This
    已经开发了Rh(III)催化的3-芳基-5-异恶唑酮与马来酰亚胺或顺丁烯二酸酯的[4 + 2]环化反应,从而以良好的产率获得了重要的合成3,4-二氢异喹啉衍生物。这种简便的方案可以耐受各种官能团,并且产生了CO 2作为主要副产物。值得注意的是,CC键和CN键是同时形成的。该协议可以轻松扩展。
  • Palladium Catalyzed Insertion Reaction of Isocyanides with 3-Arylisoxazol-5(4<i>H</i>)-ones: Synthesis of 4-Aminomethylidene Isoxazolone Derivates
    作者:Yi-Ming Zhu、Pei Xu、Shun-Yi Wang、Shun-Jun Ji
    DOI:10.1021/acs.joc.9b01585
    日期:2019.9.6
    A palladium catalyzed insert reaction of isocyanides to 3-arylisoxazol-5(4H)-ones for the construction of 4-aminomethylidene isoxazolone derivates is reported. In this transformation, only the C–H bond of the methylene group was involved while the remaining ring structure was retained. In general, this work provided a new protocol for the synthesis of 4-aminomethylidene isoxazolones.
    报道了钯催化的异氰酸酯与3-芳基异恶唑-5(4 H)-的插入反应,用于构建4-氨基亚甲基异恶唑酮衍生物。在这种转变中,仅涉及亚甲基的C–H键,而保留了其余的环结构。通常,这项工作为4-氨基亚甲基异恶唑酮的合成提供了新的协议。
  • Iodine-catalyzed synthesis of sulfonyl isoxazoles from sodium sulfinates and isoxazol-5(4H)-ones
    作者:Dong Tang、Zafar Iqbal、Jian Sun、Jingwen Ji、Minghua Yang、Zhixiang Yang
    DOI:10.1016/j.tetlet.2020.152685
    日期:2021.1
    An efficient I2-mediated sulfonylation at 4-position of isoxazoles has been developed by employing sodium sulfinate and 3-substituted isoxazol-5(4H)-ones. This metal-free, one-pot strategy provides various sulfonyl isoxazoles under mild reaction conditions. The final product exists in the form of stable organic sodium salt, which can be purified by column chromatography under air.
    通过使用亚磺酸钠和3-取代的异恶唑-5(4H)-酮,已经开发了在异恶唑的4-位的有效的I 2-介导的磺酰化。这种无金属的单锅策略可在温和的反应条件下提供各种磺酰基异恶唑。最终产物以稳定的有机钠盐形式存在,可以通过柱色谱法在空气中纯化。
  • Discovery of a nonpeptidic small molecule antagonist of the human platelet thrombin receptor (PAR-1)
    作者:Philippe G Nantermet、James C Barrow、George F Lundell、Janetta M Pellicore、Kenneth E Rittle、MaryBeth Young、Roger M Freidinger、Thomas M Connolly、Cindra Condra、Jerzy Karczewski、Rodney A Bednar、Stanley L Gaul、Robert J Gould、Kris Prendergast、Harold G Selnick
    DOI:10.1016/s0960-894x(01)00745-4
    日期:2002.2
    The synthesis and biological evaluation of a series of nonpeptidic small molecule antagonists of the human platelet thrombin receptor (PAR-1) are described. Optimization of the 5-amino-3-arylisoxazole lead resulted in an approximate 100-fold increase in potency. The most potent of these compounds (54) inhibits platelet activation with IC50S of 90 nM against the thrombin receptor agonist peptide (TRAP) and 510 nM against thrombin as the agonist. Further, antagonist 54 fully blocks platelet aggregation stimulated by 1 nM thrombin for 10 min. (C) 2002 Published by Elsevier Science Ltd.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐